Ir para o conteúdo
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • Anti-CD20 therapy reduces micr...
  • Citar
  • Enviar por SMS
  • Enviar por email
  • Imprimir
  • Exportar registo
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
  • Permanent link
Anti-CD20 therapy reduces microglial activation and lesion volume in focal models of pattern I and pattern II multiple sclerosis

Anti-CD20 therapy reduces microglial activation and lesion volume in focal models of pattern I and pattern II multiple sclerosis

Show other versions (1)
Detalhes bibliográficos
Main Authors: Anthony, D, Campbell, S, Dickens, A, Checa, B, Kersemans, V, Seneca, N, Balazs, M, Leppert, D
Formato: Conference item
Publicado em: 2012
  • Exemplares
  • Descrição
  • Other Versions (1)
  • Registos relacionados
  • Registo fonte

Registos relacionados

  • Anti-CD20 Therapy Reduces Microglial Activation and Lesion Volume in Focal Models of Pattern I and Pattern II Multiple Sclerosis
    Por: Leppert, D, et al.
    Publicado em: (2012)
  • Anti-CD20 therapy down-regulates lesion formation and microglial activation in pattern I and pattern II rat models of multiple sclerosis
    Por: Anthony, D, et al.
    Publicado em: (2014)
  • Anti-CD20 therapy reduces lesion volume and activated microglia in rodent models of multiple sclerosis
    Por: Seneca, N, et al.
    Publicado em: (2012)
  • Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.
    Por: Anthony, D, et al.
    Publicado em: (2014)
  • Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
    Por: Anthony, D, et al.
    Publicado em: (2009)

Opções de Pesquisa

  • Histórico de Pesquisas
  • Pesquisa Avançada

Encontrar Mais

  • Percorrer o Catálogo
  • Percorrer por ordem alfabética
  • Explore Channels
  • Bibliografia Recomendada
  • Novos exemplares

Precisa de ajuda?

  • Dicas de Pesquisa
  • Serviço de Referência
  • FAQs